NO20063868L - Vedvarende frigivende farmasoytisk sammensetning av indapamid - Google Patents

Vedvarende frigivende farmasoytisk sammensetning av indapamid

Info

Publication number
NO20063868L
NO20063868L NO20063868A NO20063868A NO20063868L NO 20063868 L NO20063868 L NO 20063868L NO 20063868 A NO20063868 A NO 20063868A NO 20063868 A NO20063868 A NO 20063868A NO 20063868 L NO20063868 L NO 20063868L
Authority
NO
Norway
Prior art keywords
indapamide
sustained
pharmaceutical composition
release pharmaceutical
prepared
Prior art date
Application number
NO20063868A
Other languages
English (en)
Inventor
Franc Vrecer
Stanka Perc
Andrejka Kramar
Original Assignee
Krka Tovarna Zdravil Dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil Dd filed Critical Krka Tovarna Zdravil Dd
Publication of NO20063868L publication Critical patent/NO20063868L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Vedvarende frigivelsessammensetninger av indapamid beskrives som kan fremstilles ved en direkte kompresjonsblanding og en høy grad av jevnt innhold.
NO20063868A 2004-01-30 2006-08-30 Vedvarende frigivende farmasoytisk sammensetning av indapamid NO20063868L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004005009A DE102004005009A1 (de) 2004-01-30 2004-01-30 Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid
PCT/EP2005/000886 WO2005074884A2 (en) 2004-01-30 2005-01-28 Sustained release pharmaceutical composition of indapamide

Publications (1)

Publication Number Publication Date
NO20063868L true NO20063868L (no) 2006-10-20

Family

ID=34813079

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063868A NO20063868L (no) 2004-01-30 2006-08-30 Vedvarende frigivende farmasoytisk sammensetning av indapamid

Country Status (8)

Country Link
EP (1) EP1713452B1 (no)
AT (1) ATE461694T1 (no)
DE (2) DE102004005009A1 (no)
EA (1) EA011810B1 (no)
NO (1) NO20063868L (no)
UA (1) UA89628C2 (no)
WO (1) WO2005074884A2 (no)
ZA (1) ZA200607156B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
RU2288713C1 (ru) * 2005-10-27 2006-12-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Состав пролонгированного действия, обладающий антигипертензивной и диуретической активностью, и способ его получения
PL204780B1 (pl) * 2006-06-02 2010-02-26 Zak & Lstrok Ady Farmaceutyczn Tabletka powlekana o przedłużonym uwalnianiu substancji aktywnej otrzymywana metodą bezpośredniego tabletkowania zawierająca indapamid albo jego farmaceutyczną sól oraz farmaceutycznie dopuszczalne wypełniacze, zastosowanie karbomeru do wytwarzania tabletki oraz sposób jej powlekania
EP2380561A1 (en) 2010-04-21 2011-10-26 LEK Pharmaceuticals d.d. Extended release formulation comprising indapamide
CN105012275B (zh) * 2015-08-20 2018-03-27 广东安诺药业股份有限公司 吲达帕胺缓释剂制备方法
EP4103158B1 (en) * 2020-02-10 2024-09-04 Adamed Pharma S.A. Composition comprising ramipril and indapamide
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
EP1057479A1 (en) * 1994-12-14 2000-12-06 Enbalt Trading Limited Pharmaceutical tablet formulations for direct compression
PL193976B1 (pl) * 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid

Also Published As

Publication number Publication date
ATE461694T1 (de) 2010-04-15
EP1713452A2 (en) 2006-10-25
WO2005074884A3 (en) 2005-12-08
DE602005020116D1 (de) 2010-05-06
UA89628C2 (ru) 2010-02-25
ZA200607156B (en) 2007-11-28
EA200600957A1 (ru) 2006-12-29
DE102004005009A1 (de) 2005-09-01
WO2005074884A2 (en) 2005-08-18
EP1713452B1 (en) 2010-03-24
EA011810B1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
ATE502921T1 (de) Substituierte indole
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
SG153800A1 (en) Pharmaceutical compositions
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
EA200870475A1 (ru) Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
EA200870472A1 (ru) Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1
MX2010004028A (es) 4-[3-(4-ciclopropancarbonil-piperacin-1-carbonil)-4-fluoro-bencil ]-2h-ftalacin-1-ona.
BRPI0913457A2 (pt) "composto, composição farmacêutica, e, uso do composto"
TW200603798A (en) Disalt inhibitors of il-12 production
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
ATE534383T1 (de) Zusammensetzungen aus n-ä2,4-bis(1,1- dimethylethyl)-5-hydroxyphenylü-1,4-dihydro-4- oxochinolin-3-carboxamid
MY169272A (en) Her2 antibody composition
EA201001711A1 (ru) Смесь связанного триптофана в составе пептидов и связанного триптофана в составе полипептидов
NO20082716L (no) Sammensetninger og fremgangsmater for fremstilling av en sammensetning
DK2021337T3 (da) Inhibitorer af 11-beta-hydroxysteroid-dehydrogenase-1
ATE472542T1 (de) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
UY28745A1 (es) Nuevos compuestos
ATE555156T1 (de) Sauerstofffänger-mischungen
NO20065726L (no) Forbindelser og sammensetninger for avlevering av aktive forbindelser.
EA200700367A1 (ru) Новые производные 4-бензилиденпиперидина
NO20063868L (no) Vedvarende frigivende farmasoytisk sammensetning av indapamid
NO20073762L (no) Visko-supplementsammensetning og fremgangsmater
EA200601279A1 (ru) Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина
TW200738649A (en) Calcilytic compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application